Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Dec-21 5:04 PM View:  | Hale David F Director | Biocept, Inc. (BIOC) | 09-Dec-21 | Sale | 374 | $4.06 | $1,518.64 | (8%) 4.46K to 4.08K | |
| 10-Dec-21 5:04 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 09-Dec-21 | Sale | 71 | $4.07 | $288.71 | (2%) 4.08K to 4.01K | |
| 12-Jun-20 9:42 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 12-Jun-20 | Market Sale | 556 | $0.56 | $308.58 | (11%) 5.01K to 4.46K | 15% |
| 12-Jun-20 9:42 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 12-Jun-20 | Market Sale | 604 | $0.56 | $335.44 | (11%) 5.62K to 5.01K | 15% |
| 06-Jun-18 4:33 PM View: | Gerhardt Bruce Director | Biocept, Inc. (BIOC) | 30-Jan-18 | Purchase | 25,000 | -- | -- | 34% 73.3K to 98.3K | |
| 02-Jun-17 4:12 PM View: | Arnold Lyle J SR VP of R&D and CSO | Biocept, Inc. (BIOC) | 31-May-17 | Grant | 25,000 | -- | -- | 38% 65.24K to 90.24K | |
| 02-Jun-17 4:11 PM View: | Kennedy Timothy CFO, Sr V.P. Operations & Sec. | Biocept, Inc. (BIOC) | 31-May-17 | Grant | 25,000 | -- | -- | 41% 61.36K to 86.36K | |
| 02-Jun-17 4:14 PM View: | Singh Veena Sr VP & Sr Med Director | Biocept, Inc. (BIOC) | 31-May-17 | Grant | 25,000 | -- | -- | 88% 28.33K to 53.33K | |
| 02-Jun-17 4:10 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 31-May-17 | Grant | 50,000 | -- | -- | 67% 74.58K to 124.58K | |
| 26-Jan-17 6:05 AM View: | Ally Bridge Lb Healthcare M... 10% Owner | Biocept, Inc. (BIOC) | 19-Jan-17 | Disposition | 254,893 | $1.10 | $280,382.00 | (100%) 254.89K to 0 | |
| 26-Jan-17 6:05 AM View: | Ally Bridge Lb Healthcare M... 10% Owner | Biocept, Inc. (BIOC) | 18-Jan-17 | Disposition | 549,708 | $1.10 | $604,679.00 | (68%) 804.6K to 254.89K | |
| 26-Jan-17 6:05 AM View: | Ally Bridge Lb Healthcare M... 10% Owner | Biocept, Inc. (BIOC) | 17-Jan-17 | Disposition | 876,399 | $1.10 | $964,039.00 | (52%) 1.68M to 804.6K | |
| 21-Oct-16 6:16 PM View: | Huebner Bruce A Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 20,000 | $1.10 | $22,000.00 | 500% 4.0K to 24.0K | |
| 21-Oct-16 6:12 PM View: | Arnold Lyle J SR VP of R&D and CSO | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 45,000 | $1.10 | $49,500.00 | 222% 20.24K to 65.24K | |
| 21-Oct-16 6:18 PM View: | Chandler Marsha Alpert Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 4,545 | $1.10 | $4,999.50 | 193% 2.36K to 6.91K | |
| 21-Oct-16 6:11 PM View: | Wilson Margaret Faye Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 13,636 | $1.10 | $14,999.60 | 107% 12.7K to 26.33K | |
| 21-Oct-16 5:04 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 90,909 | $1.10 | $99,999.90 | 117% 77.64K to 168.55K | |
| 21-Oct-16 6:06 PM View: | Reiss Claire 10% Owner | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase Duplicate | 227,272 | $1.10 | $249,999.00 | 28% 824.01K to 1.05M | |
| 21-Oct-16 6:14 PM View: | Singh Veena Sr VP & Sr Med Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 10,000 | $1.10 | $11,000.00 | 55% 18.33K to 28.33K | |
| 21-Oct-16 5:06 PM View: | Neff Edward A. Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 227,272 | $1.10 | $249,999.00 | 227% 100.1K to 327.37K | |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase Duplicate | 36,363 | $1.10 | $39,999.30 | 95% 38.21K to 74.58K | |
| 21-Oct-16 6:17 PM View: | Kennedy Timothy CFO, Sr V.P. Operations & Sec. | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 36,363 | $1.10 | $39,999.30 | 145% 25.0K to 61.36K | |
| 21-Oct-16 6:15 PM View: | Gerhardt Bruce Director | Biocept, Inc. (BIOC) | 19-Oct-16 | Purchase | 50,000 | $1.10 | $55,000.00 | 215% 23.3K to 73.3K | |
| 01-Aug-16 5:28 PM View: | Kennedy Timothy CFO, Sr V.P. Operations & Sec. | Biocept, Inc. (BIOC) | 29-Jul-16 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 07-Jul-16 4:18 PM View: | Arnold Lyle J SR VP of R&D and CSO | Biocept, Inc. (BIOC) | 06-Jul-16 | Grant | 50,000 | -- | -- | 467% 10.71K to 60.71K | |
| 07-Jul-16 4:17 PM View: | Singh Veena Sr VP & Sr Med Director | Biocept, Inc. (BIOC) | 06-Jul-16 | Grant | 50,000 | -- | -- | 1000% 5.0K to 55.0K | |
| 07-Jul-16 4:19 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 06-Jul-16 | Grant | 75,000 | -- | -- | 189% 39.63K to 114.63K | |
| 21-Oct-16 5:04 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 16-Jun-16 | Gift | 13,334 | -- | -- | 17% 77.64K to 90.98K | |
| 21-Oct-16 5:04 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 16-Jun-16 | Gift | 13,334 | -- | -- | (15%) 90.98K to 77.64K | |
| 05-May-16 8:29 PM View: | Hale David F Director | Biocept, Inc. (BIOC) | 04-May-16 | Market Purchase | 50,000 | $1.00 | $50,000.00 | 27% 182.93K to 232.93K | (100%) |
| 05-May-16 8:26 PM View: | Reiss Claire 10% Owner | Biocept, Inc. (BIOC) | 04-May-16 | Market Purchase | 614,273 | $1.00 | $614,273.00 | 33% 1.86M to 2.47M | (100%) |
| 05-May-16 8:28 PM View: | Neff Edward A. Director | Biocept, Inc. (BIOC) | 04-May-16 | Market Purchase | 100,000 | $1.00 | $100,000.00 | 50% 200.3K to 300.3K | (100%) |
| 05-May-16 8:27 PM View: | Gerhardt Bruce Director | Biocept, Inc. (BIOC) | 04-May-16 | Market Purchase | 25,000 | $1.00 | $25,000.00 | 74% 33.98K to 58.98K | (100%) |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 09-Mar-16 | Gift | 4,450 | -- | -- | 12% 38.21K to 42.66K | |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 09-Mar-16 | Gift | 4,450 | -- | -- | (10%) 42.66K to 38.21K | |
| 01-Mar-16 4:09 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 29-Feb-16 | Grant | 13,348 | -- | -- | 51% 26.29K to 39.63K | |
| 10-Nov-15 4:51 PM View: | Royston Ivor Director | Biocept, Inc. (BIOC) | 09-Nov-15 | Option Exercise | 9,285 | -- | -- | 36% 25.59K to 34.88K | |
| 10-Nov-15 4:50 PM View: | Hale David F CHAIRMAN Director | Biocept, Inc. (BIOC) | 09-Nov-15 | Option Exercise | 63,866 | -- | -- | 54% 119.06K to 182.93K | |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 01-Sep-15 | Gift | 4,762 | -- | -- | (11%) 42.97K to 38.21K | |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 01-Sep-15 | Gift | 4,762 | -- | -- | 12% 38.21K to 42.97K | |
| 25-Aug-15 5:35 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 24-Aug-15 | Option Exercise | 14,286 | -- | -- | 119% 12.0K to 26.29K | |
| 25-Aug-15 5:34 PM View: | Hale David F CHAIRMAN Director | Biocept, Inc. (BIOC) | 24-Aug-15 | Option Exercise | 14,286 | -- | -- | 14% 104.77K to 119.06K | |
| 25-Aug-15 5:33 PM View: | Arnold Lyle J SR VP of R&D and CSO | Biocept, Inc. (BIOC) | 24-Aug-15 | Option Exercise | 10,714 | -- | -- | 100% 0 to 10.71K | |
| 02-Jun-15 2:04 PM View: | Singh Veena Sr VP & Sr Med Director | Biocept, Inc. (BIOC) | 01-Jun-15 | Market Purchase | 3,200 | $3.10 | $9,920.00 | 178% 1.8K to 5.0K | (100%) |
| 02-Jun-15 2:04 PM View: | Singh Veena Sr VP & Sr Med Director | Biocept, Inc. (BIOC) | 29-May-15 | Market Purchase | 1,800 | $3.05 | $5,490.00 | 100% 0 to 1.8K | (100%) |
| 08-Jul-15 2:27 PM View: | Royston Ivor Director | Biocept, Inc. (BIOC) | 24-May-15 | Option Exercise | 8,735 | -- | -- | 52% 16.86K to 25.59K | |
| 08-Jul-15 2:25 PM View: | Neff Edward A. Director | Biocept, Inc. (BIOC) | 24-May-15 | Option Exercise | 8,735 | -- | -- | 5% 191.56K to 200.3K | |
| 08-Jul-15 2:31 PM View: | Wilson Margaret Faye Director | Biocept, Inc. (BIOC) | 24-May-15 | Option Exercise | 14,285 | -- | -- | 111% 12.87K to 27.15K | |
| 08-Jul-15 2:32 PM View: | Gerhardt Bruce Director | Biocept, Inc. (BIOC) | 24-May-15 | Option Exercise | 8,735 | -- | -- | 35% 25.25K to 33.98K | |
| 21-Oct-16 6:43 PM View: | Nall Michael W. CEO & President Director | Biocept, Inc. (BIOC) | 30-Apr-15 | Gift | 4,000 | -- | -- | (9%) 42.21K to 38.21K |
